Agilus

dantrolene sodium, hemiheptahydrate · Norgine B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Agilus, covering 2017-08-17 to 2024-07-18. Get the full timeline:

Most recent: EMA Authorised: Agilus (dantrolene sodium, hemiheptahydrate) — Norgine B.V.